APA (7th ed.) Citation

Riemenschneider, M. J., Fischer, J., Grassow-Narlik, M., Mawrin, C., Deimling, A. v., Pietsch, T., . . . Rothhammer-Hampl, T. (2020). Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019. Clinical neuropathology, 39(5), . https://doi.org/10.5414/NP301278

Chicago Style (17th ed.) Citation

Riemenschneider, Markus Johannes, et al. "Quality Assurance in Neuropathology: Experiences from the Round Robin Trials on IDH Mutation and MGMT Promoter Methylation Testing Launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019." Clinical Neuropathology 39, no. 5 (2020). https://doi.org/10.5414/NP301278.

MLA (9th ed.) Citation

Riemenschneider, Markus Johannes, et al. "Quality Assurance in Neuropathology: Experiences from the Round Robin Trials on IDH Mutation and MGMT Promoter Methylation Testing Launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019." Clinical Neuropathology, vol. 39, no. 5, 2020, https://doi.org/10.5414/NP301278.